The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 10, 2024
Filed:
Jun. 21, 2019
Applicant:
Robert John Petcavich, The Woodlands, TX (US);
Inventor:
Robert John Petcavich, The Woodlands, TX (US);
Assignee:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/48 (2006.01); A61K 9/00 (2006.01); A61K 9/70 (2006.01); A61K 31/05 (2006.01); A61K 31/12 (2006.01); A61K 31/137 (2006.01); A61K 31/15 (2006.01); A61K 31/155 (2006.01); A61K 31/352 (2006.01); A61K 31/353 (2006.01); A61K 31/355 (2006.01); A61K 31/36 (2006.01); A61K 31/375 (2006.01); A61K 31/4045 (2006.01); A61K 31/426 (2006.01); A61K 31/675 (2006.01); A61K 31/706 (2006.01); A61K 45/06 (2006.01); A61P 25/28 (2006.01);
U.S. Cl.
CPC ...
A61K 31/48 (2013.01); A61K 9/006 (2013.01); A61K 9/7007 (2013.01); A61K 31/05 (2013.01); A61K 31/12 (2013.01); A61K 31/137 (2013.01); A61K 31/15 (2013.01); A61K 31/155 (2013.01); A61K 31/352 (2013.01); A61K 31/353 (2013.01); A61K 31/355 (2013.01); A61K 31/36 (2013.01); A61K 31/375 (2013.01); A61K 31/4045 (2013.01); A61K 31/426 (2013.01); A61K 31/675 (2013.01); A61K 31/706 (2013.01); A61K 45/06 (2013.01); A61P 25/28 (2018.01);
Abstract
The present invention discloses a method to recover and restore dendritic and synaptic neuron connections that have been degraded or destroyed by neurodegenerative diseases. In the present invention tryptamines are used to induce neuro plasticity and restore both dendritic density and synaptic connections of neurons in the brain. In the preferred embodiment LSD given in micro doses can induce dendritic and synaptic genesis in neuronal networks and improve the quality of life of people with neurodegenerative diseases such as Alzheimer's, Huntington's, Multiple Sclerosis, Parkinson's and Frontotemporal dementia.